EVFM
EVFM clinical trials: Evofem Biosciences, Inc.
Every trial on ClinicalTrials.gov where Evofem Biosciences, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 7
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
EVFM on the catalyst calendar · EVFM registry changes
- Primary completion Jul 28, 2022ActualPhase 3NCT04553068Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae InfectionEvofem Inc. · Sexually Transmitted DiseasesCompletedEVFMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2014ActualPhase 3NCT01306331Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal GelEvofem Inc. · ContraceptionCompletedEVFMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 12, 2016ActualPhase 1NCT02693418Duration of Effect of Acidform Gel on Vaginal pHEvofem Inc. · HealthyCompletedEVFMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 29, 2018ActualPhase 3NCT03243305AMP002 Phase III Contraceptive StudyEvofem Inc. · ContraceptionCompletedEVFMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 22, 2019ActualPhase 2/Phase 3NCT03107377Phase 2B/3 Double-blinded Placebo-controlledEvofem Inc. · Chlamydia Trachomatis InfectionCompletedEVFMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 23, 2015ActualPhase 3NCT02483533Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202Evofem Inc. · Central Abdominal BulgingTerminatedEVFMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 29, 2015ActualPhase 3NCT02398188Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)Evofem Inc. · Central Abdominal BulgingCompletedEVFMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner